Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Dragonfly Therapeutics
Dana-Farber Cancer Institute
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Genentech, Inc.
MacroGenics
Innate Pharma
Novartis
OncoNano Medicine, Inc.
City of Hope Medical Center
University Health Network, Toronto
NeoTX Therapeutics Ltd.
West China Hospital
HiFiBiO Therapeutics
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
MacroGenics
Pfizer
Pfizer
Arcus Biosciences, Inc.
Toray Industries, Inc
University of Virginia
Turnstone Biologics, Corp.
Theratechnologies
Revolution Medicines, Inc.
Seagen Inc.
Checkpoint Therapeutics, Inc.
Sotio Biotech Inc.
Eli Lilly and Company
AstraZeneca
Astellas Pharma Inc
Molecular Templates, Inc.
NGM Biopharmaceuticals, Inc
Xencor, Inc.
ADC Therapeutics S.A.
Pliant Therapeutics, Inc.
ABM Therapeutics Corporation
Pfizer
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
BioEclipse Therapeutics
Hefei TG ImmunoPharma Co., Ltd.
Adaptimmune